Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Pulmonary alveolar proteinosis is a rare disease in childhood, generally found in infants less than 1 year old. Survival time averages less than one year after the onset of symptoms, which consist mainly of cough and dyspnea. Of the 23 patients with pulmonary alveolar proteinosis, seven had thymic alymphoplasia (30%); this association leads to speculation that the immuno-logic system may be incompetent or contribute to the etiology of the disease. The diagnosis of pulmonary alveolar proteinosis is confirmed by biopsy, although chest roentgenograms and sputum staining may be helpful. Therapy consists of the use of steroids, antibiotics, and inhalation therapy; bronchopulmonary lavage has been unsuccessful in children. Si nce the original description of pulmonary alveolar proteinosis by Rosen et al1 in 1958, 139 adult cases have been reported.2 The dis¬ ease is rarer in childhood, and only 22 cases have been reported to date.1-3-12 We present the 23rd case and a review of the previous 22 cases. Report of a CaseA white girl, 7 years 2 months old, was first referred to this clinic when she was 6 years 2 months old because of pneumonia in the middle lobe of the right lung, leuko¬ penia, and fever. At the age of 5 years, she was given griseofulvin for a ring¬ worm-like lesion of the abdomen. At that time, leukopenia was first noted (white blood cell count [WBC] 3,000/cu mm). A biopsy of the lesion reportedly showed nonspecific vasculitis, and the child was treated with steroids for ten days. Dur¬ ing the next year, the lesion disappeared spontaneously, but upper-respiratory tract infection recurred and the leukopenia per¬ sisted.On first admission to our clinic, June 26, 1969, she was in moderate respiratory dis¬ tress and had a temperature of 103 F (39.4 C) and rales in both lung bases. A chest roentgenogram showed a diffuse in¬ terstitial infiltrate (Fig 1, left). Cultures of blood and bronchial washings were negative, and bone marrow examination showed no abnormality. Multiple skin tests for fungi and tubercle bacilli were negative. Tests for rheumatoid factor and lupus erythematosus cells were negative. Serum IgA, IgM, and IgG concentrations were, respectively, 1.45, 1.35, and 14.5 mg/100 ml. The leukopenia persisted (3,000 WBC /cu mm), with a normal differential cell count. Open lung biopsy showed a recent and an old intraalveolar hemorrhage suggestive of pulmonary hemosiderosis, as well as mild subacute and chronic interstitial pneumonitis. Gas¬ tric aspirates were negative for hemosiderin. Treatment consisted of ampicillin and supportive therapy. The fever sub¬ sided, and she was dismissed on July 3, at which time she was receiving 30 nig of prednisone per day. Three episodes of bronchitis, pneu¬ monitis, and fever occurred before her final admission on May 9, 1970, at the age of 7 years. Figure 1, center, shows a chest x-ray film that was taken during one of those episodes. At the final admission, the chief complaints were fever, dyspnea, cyanosis, and cough productive of clear sputum. There was no hemoptysis. ...
Pulmonary alveolar proteinosis is a rare disease in childhood, generally found in infants less than 1 year old. Survival time averages less than one year after the onset of symptoms, which consist mainly of cough and dyspnea. Of the 23 patients with pulmonary alveolar proteinosis, seven had thymic alymphoplasia (30%); this association leads to speculation that the immuno-logic system may be incompetent or contribute to the etiology of the disease. The diagnosis of pulmonary alveolar proteinosis is confirmed by biopsy, although chest roentgenograms and sputum staining may be helpful. Therapy consists of the use of steroids, antibiotics, and inhalation therapy; bronchopulmonary lavage has been unsuccessful in children. Si nce the original description of pulmonary alveolar proteinosis by Rosen et al1 in 1958, 139 adult cases have been reported.2 The dis¬ ease is rarer in childhood, and only 22 cases have been reported to date.1-3-12 We present the 23rd case and a review of the previous 22 cases. Report of a CaseA white girl, 7 years 2 months old, was first referred to this clinic when she was 6 years 2 months old because of pneumonia in the middle lobe of the right lung, leuko¬ penia, and fever. At the age of 5 years, she was given griseofulvin for a ring¬ worm-like lesion of the abdomen. At that time, leukopenia was first noted (white blood cell count [WBC] 3,000/cu mm). A biopsy of the lesion reportedly showed nonspecific vasculitis, and the child was treated with steroids for ten days. Dur¬ ing the next year, the lesion disappeared spontaneously, but upper-respiratory tract infection recurred and the leukopenia per¬ sisted.On first admission to our clinic, June 26, 1969, she was in moderate respiratory dis¬ tress and had a temperature of 103 F (39.4 C) and rales in both lung bases. A chest roentgenogram showed a diffuse in¬ terstitial infiltrate (Fig 1, left). Cultures of blood and bronchial washings were negative, and bone marrow examination showed no abnormality. Multiple skin tests for fungi and tubercle bacilli were negative. Tests for rheumatoid factor and lupus erythematosus cells were negative. Serum IgA, IgM, and IgG concentrations were, respectively, 1.45, 1.35, and 14.5 mg/100 ml. The leukopenia persisted (3,000 WBC /cu mm), with a normal differential cell count. Open lung biopsy showed a recent and an old intraalveolar hemorrhage suggestive of pulmonary hemosiderosis, as well as mild subacute and chronic interstitial pneumonitis. Gas¬ tric aspirates were negative for hemosiderin. Treatment consisted of ampicillin and supportive therapy. The fever sub¬ sided, and she was dismissed on July 3, at which time she was receiving 30 nig of prednisone per day. Three episodes of bronchitis, pneu¬ monitis, and fever occurred before her final admission on May 9, 1970, at the age of 7 years. Figure 1, center, shows a chest x-ray film that was taken during one of those episodes. At the final admission, the chief complaints were fever, dyspnea, cyanosis, and cough productive of clear sputum. There was no hemoptysis. ...
Three cancer patients developed pulmonary distress during treatment with bieomycin. Light microscopic examination of lung tissue obtained by percutaneous biopsy revealed a diffuse alveolar damage progressing to interstitial pneumonitis. With electron microscopy, interstitial adema and collagen deposition, accumulation of fibroblasts, disappearance of type I, and proliferation of type II alveolar epithelial cells were noted. Alveoli contained proteinaceous material and a mixture of macrophages and type II cells. A peculiar alteration was noted in some type II cells consisting of shortening of the microvilli and extrusion of cytoplasmic lamellar bodies with possible surfactant impairment. These findings are consistent with the drug's effect upon the alveolar epithelium. Bleomycin, therefore, can be considered another etiologic agent of iatrogenic interstitial pneumonitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.